Neoadjuvant chemotherapy in stage X ovarian carcinoma
Open Access
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (3) , 327-331
- https://doi.org/10.1016/0090-8258(90)90361-n
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic testGynecologic Oncology, 1987
- Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancerGynecologic Oncology, 1987
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)American Journal of Obstetrics and Gynecology, 1983
- Second-look operations in the planned management of advanced ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1982
- Review of ovarian cancer at the University of Texas Systems Cancer Center, M. D. Anderson Hospital and Tumor InstituteAmerican Journal of Obstetrics and Gynecology, 1979
- Chemotherapy in the treatment of cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958